Caffeine citrate in the NICU.
Administering caffeine citrate is a safe, noninvasive way to treat premature infants with persistent apnea. This drug decreases the frequency of apneic episodes, thus reducing the need for mechanical ventilation. It is given once a day, either orally or intravenously. Ideally, caffeine citrate can treat apnea of prematurity and prevent insults to the premature infant's neurological status.
Flood
E
E
D001049:Apnea / Q000188:drug therapy* / Q000451:nursing; D002110:Caffeine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002951:Citrates / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000451:nursing; D007363:Intensive Care Units, Neonatal
D002951:Citrates; D004338:Drug Combinations; D002110:Caffeine; C026189:caffeine citrate